123tom, since this is a news driven stock, like all bios. When the much bigger Parkinson Dementia and secondary Parkinson Disease is PRed no later than the end of this month, next wed, I do not see that run up in your analysis.
If the news is good as we expect based on data released so far, where do you see the SP after good to better than good news is released??
Technicals work good on Dow and S&P more stable stocks, but not so much with biotechs driven on good news or lack of it.
So where do you see the SP going when PDD/PD is announced?